2018
DOI: 10.1111/1346-8138.14647
|View full text |Cite
|
Sign up to set email alerts
|

Intestinal barrier integrity in patients with plaque psoriasis

Abstract: Psoriasis is a chronic inflammatory systemic disease. Growing evidence suggests that human homeostasis depends on a mutualistic relationship with gut bacteria that produce a number of biologically active compounds. Therefore, enteric microbiota dysbiosis with gut barrier disruption may be an important factor in the development of chronic inflammatory diseases. The aim of our study was to assess non-invasive markers of intestinal barrier integrity in patients with moderate to severe psoriasis. Concentrations of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
36
0
6

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 53 publications
(49 citation statements)
references
References 14 publications
7
36
0
6
Order By: Relevance
“…The results of the present study confirm and expand our previous results that psoriasis is associated with disruption of the gastrointestinal barrier …”
Section: Discussionsupporting
confidence: 92%
“…The results of the present study confirm and expand our previous results that psoriasis is associated with disruption of the gastrointestinal barrier …”
Section: Discussionsupporting
confidence: 92%
“…Furthermore, alterations in the composition of gut microbiome have been observed in patients with psoriasis. A decrease in phylum of Actinobacteria , which includes Bifidobacterium species of a known immunosuppressive activity, and perturbations in the balance of Firmicutes and Bacteroidetes , along with recent findings of an increased intestinal permeability, supports a new concept of a “gut‐skin axis” in psoriasis …”
Section: Changes Of the Hair Follicle Microbiome In Scalp Diseasesmentioning
confidence: 70%
“…Alterations in gut microflora may also lead to intestinal barrier disintegration. Higher levels of claudin‐3 and intestinal fatty acid binding protein, the markers of intestinal barrier damage, were noticed among patients with psoriasis …”
Section: Methodsmentioning
confidence: 99%
“…Higher levels of claudin-3 and intestinal fatty acid binding protein, the markers of intestinal barrier damage, were noticed among patients with psoriasis. 55 The studies concerning the coexistence of SIBO with psoriasis remain contradictory. Nevertheless, SIBO eradication has been associated with cutaneous lesions amelioration.…”
Section: Psoriasis and Psoriatic Arthritismentioning
confidence: 99%